
Cevidoplenib dimesylate
CAS No. 2043659-93-2
Cevidoplenib dimesylate( —— )
Catalog No. M28223 CAS No. 2043659-93-2
Cevidoplenib dimesylate is an inhibitor of spleen tyrosine kinase (Syk), possessing anti-inflammatory and immunomodulating properties.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 282 | Get Quote |
![]() ![]() |
10MG | 447 | Get Quote |
![]() ![]() |
25MG | 714 | Get Quote |
![]() ![]() |
50MG | 1017 | Get Quote |
![]() ![]() |
100MG | 1368 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCevidoplenib dimesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCevidoplenib dimesylate is an inhibitor of spleen tyrosine kinase (Syk), possessing anti-inflammatory and immunomodulating properties.
-
DescriptionCevidoplenib dimesylate is an inhibitor of spleen tyrosine kinase (Syk), possessing anti-inflammatory and immunomodulating properties.(In Vitro):Cevidoplenib dimesylate inhibits the activity of SYK through binding to SYK, blocking Fc receptor and B-cell receptor (BCR)-mediated signaling in inflammatory cells, including macrophages, neutrophils, mast cells, natural killer (NK) cells, and B cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetSyk
-
RecptorHSF1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2043659-93-2
-
Formula Weight665.74
-
Molecular FormulaC27H35N7O9S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (37.55 mM)
-
SMILESCC1=NN(C2=NC(NC3=CC4=C(N(C)C=C4C(C5CC5)=O)C=C3)=NC=C2)C=C1CN6C[C@H](O)CO6.CS(=O)(O)=O.CS(=O)(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Keith Jones, et al. Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1. WO2015049535A1.
molnova catalog



related products
-
OXSI-2
OXSI-2 is an inhibitor of Syk with an EC50 of 313 nM and an IC50 of 14 nM. OXSI-2 completely inhibits Adaptor protein LAT Y191 phosphorylation and Syk mediated events in platelets.
-
Mitapivat
Mitapivat, also known as PKM2 activator 1020 is a PKM2 activator (pyruvate kinase activator) for the treatment of pyruvate kinase deficiency.
-
BAY 61-3606 dihydroc...
A potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase with Ki of 7.5 nM.